• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VERSAPOINT ELECTRODE UNKNOWN PRODUCT; HYSTEROSCOPE (AND ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VERSAPOINT ELECTRODE UNKNOWN PRODUCT; HYSTEROSCOPE (AND ACCESSORIES) Back to Search Results
Catalog Number VERSAUNK
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.The single complaint was reported with multiple events.There are no additional details regarding the additional events.Citation: reproductive sciences 00(0) 1-7, doi: 10.1177/1933719112466308.Reproductive sciences published online 10 december 2012.(b)(4).
 
Event Description
Title: a multicenter, double-blind, randomized, placebo-controlled study to assess whether antibiotic administration should be recommended during office operative hysteroscopy.This multicenter, double-blind, randomized, placebo-controlled study aimed to assess the incidence of infectious complications and the protective effect of prophylactic antibiotic during operative hysteroscopic procedures in an office setting.Between january and october 2010, a total of 1046 patients undergoing office hysteroscopy during the immediate postmenstrual phase of the menstrual cycle (6th-10th day, computed on the base of the last menstrual period as referred by patients) were included in the study.The patients were randomly assigned to either reference group (n=523; mean age of 36.3 years, mean bmi of 24.8) where 1 g of cefazolin was intramuscularly (im) administered during hysteroscopic procedure; and study group (n=523; mean age of 42.1 years, mean bmi of 26.6), where patients were administered with 10 ml of isotonic sodium chloride solution (the placebo) during hysteroscopic procedure.Operative procedures include polypectomy, synechiolysis, metroplasty, and myomectomy.After panoramic visualization of the entire uterine cavity, the operative procedures were performed with standard techniques using grasping forceps, scissors, and bipolar electrodes (versapoint gynecare, ethicon).Complaints included postsurgical infectious complications (n=12).In details, 7 patients who had complications belong to the study (untreated) group [polypectomy (n=2), synechiolysis (n=1), metroplasty (n=2), myomectomy (n=1), others (n=1)] and 5 from the reference group [polypectomy (n=3), metroplasty (n=1), myomectomy (n=1)].Antibiotics were prescribed in all cases of postsurgical infection and the infective process resolved in few days.The results presented in this study would support the american college of obstetricians and gynecologists recommendation not to prescribe routine antibiotic administration in the case of hysteroscopic surgery, considering the low risk of infectious complications after hysteroscopy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSAPOINT ELECTRODE UNKNOWN PRODUCT
Type of Device
HYSTEROSCOPE (AND ACCESSORIES)
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
Manufacturer (Section G)
ETHICON INC.-GYRUS MEDICAL LTD
fortran road
cardiff
Manufacturer Contact
kara ditty-bovard
p.o. box 151, route 22 west
somerville, NJ 08876
6107428552
MDR Report Key9239188
MDR Text Key167204583
Report Number2210968-2019-89055
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K040302
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other
Type of Report Initial
Report Date 09/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/25/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVERSAUNK
Was Device Available for Evaluation? No
Date Manufacturer Received09/27/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-